Illustrative image – not actual.Aurobindo Pharma has plans to set up a manufacturing unit in Los Angeles to make sterile cephalosporins for the US market. The project is estimated to cost $8 million.
The project would be set up as a joint venture with
MedPharmix Inc. Both partners would invest $4 million in the new venture called
– Cephazone Inc.
The new unit is expected to become operational in the
first quarter of 2003-04.
Meanwhile, in India, Aurobindo Pharma is setting up a
bulk drugs unit in Visakhapatnam in Andhra Pradesh with an investment of Rs.35
crore. This unit is expected to commence operations in May 2002.
